Teladoc Health [TDOC] vs GoodRx Holdings [GDRX] Detailed Stock Comparison
Teladoc Health
NYSE
Loading...
GoodRx Holdings
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Teladoc Health wins in 9 metrics, GoodRx Holdings wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Teladoc Health | GoodRx Holdings | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.31 | 49.89 | Teladoc Health |
| Price-to-Book Ratio | 0.95 | 2.43 | Teladoc Health |
| Debt-to-Equity Ratio | 72.78 | 85.15 | Teladoc Health |
| PEG Ratio | 0.01 | 0.50 | Teladoc Health |
| EV/EBITDA | 86.11 | 13.57 | GoodRx Holdings |
| Profit Margin (TTM) | -8.16% | 4.33% | GoodRx Holdings |
| Operating Margin (TTM) | -7.29% | 13.20% | GoodRx Holdings |
| EBITDA Margin (TTM) | N/A | 13.20% | N/A |
| Return on Equity | -14.18% | 5.27% | GoodRx Holdings |
| Return on Assets (TTM) | -3.57% | 5.08% | GoodRx Holdings |
| Free Cash Flow (TTM) | $169.63M | $113.55M | Teladoc Health |
| 1-Year Return | 3.50% | -44.59% | Teladoc Health |
| Price-to-Sales Ratio (TTM) | 0.53 | 1.95 | Teladoc Health |
| Enterprise Value | $1.63B | $1.83B | GoodRx Holdings |
| EV/Revenue Ratio | 0.64 | 2.28 | Teladoc Health |
| Gross Profit Margin (TTM) | 69.85% | 93.43% | GoodRx Holdings |
| Revenue per Share (TTM) | $15 | $2 | Teladoc Health |
| Earnings per Share (Diluted) | $-1.15 | $0.09 | GoodRx Holdings |
| Beta (Stock Volatility) | 1.77 | 1.24 | GoodRx Holdings |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Teladoc Health vs GoodRx Holdings Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Teladoc Health | 6.82% | 2.13% | -8.79% | 11.30% | -32.57% | -19.33% |
| GoodRx Holdings | 1.56% | 22.25% | -7.32% | 19.37% | -5.79% | 0.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Teladoc Health | 3.50% | -76.07% | -96.32% | -72.29% | -72.57% | -72.57% |
| GoodRx Holdings | -44.59% | -25.37% | -91.24% | -91.24% | -91.24% | -91.24% |
Performance & Financial Health Analysis: Teladoc Health vs GoodRx Holdings
| Metric | TDOC | GDRX |
|---|---|---|
| Market Information | ||
| Market Cap | $1.36B | $1.56B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 5,593,154 | 9,322,760 |
| 90 Day Avg. Volume | 7,100,158 | 4,062,733 |
| Last Close | $7.68 | $4.56 |
| 52 Week Range | $6.35 - $15.21 | $3.31 - $8.80 |
| % from 52W High | -49.51% | -48.18% |
| All-Time High | $308.00 (Feb 15, 2021) | $64.22 (Sep 28, 2020) |
| % from All-Time High | -97.51% | -92.90% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | 0.01% |
| Quarterly Earnings Growth | -0.02% | 0.92% |
| Financial Health | ||
| Profit Margin (TTM) | -0.08% | 0.04% |
| Operating Margin (TTM) | -0.07% | 0.13% |
| Return on Equity (TTM) | -0.14% | 0.05% |
| Debt to Equity (MRQ) | 72.78 | 85.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.05 | $1.84 |
| Cash per Share (MRQ) | $3.85 | $0.81 |
| Operating Cash Flow (TTM) | $303.43M | $190.60M |
| Levered Free Cash Flow (TTM) | $209.72M | $124.38M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Teladoc Health vs GoodRx Holdings
| Metric | TDOC | GDRX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.31 | 49.89 |
| Forward P/E | -8.63 | 10.95 |
| PEG Ratio | 0.01 | 0.50 |
| Price to Sales (TTM) | 0.53 | 1.95 |
| Price to Book (MRQ) | 0.95 | 2.43 |
| Market Capitalization | ||
| Market Capitalization | $1.36B | $1.56B |
| Enterprise Value | $1.63B | $1.83B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.64 | 2.28 |
| Enterprise to EBITDA | 86.11 | 13.57 |
| Risk & Other Metrics | ||
| Beta | 1.77 | 1.24 |
| Book Value per Share (MRQ) | $8.05 | $1.84 |
Financial Statements Comparison: Teladoc Health vs GoodRx Holdings
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TDOC | GDRX |
|---|---|---|
| Revenue/Sales | $629.37M | $202.97M |
| Cost of Goods Sold | $196.83M | $13.36M |
| Gross Profit | $432.54M | $189.61M |
| Research & Development | $69.96M | $31.14M |
| Operating Income (EBIT) | $-54.94M | $23.38M |
| EBITDA | $50.34M | $48.22M |
| Pre-Tax Income | $-111.27M | $16.67M |
| Income Tax | $-18.26M | $5.62M |
| Net Income (Profit) | $-93.01M | $11.05M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TDOC | GDRX |
|---|---|---|
| Cash & Equivalents | $679.62M | $300.98M |
| Total Current Assets | $1.07B | $540.21M |
| Total Current Liabilities | $401.77M | $103.38M |
| Long-Term Debt | $1.03B | $530.63M |
| Total Shareholders Equity | $1.42B | $654.35M |
| Retained Earnings | $-16.36B | $-1.43B |
| Property, Plant & Equipment | $27.67M | $34.41M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TDOC | GDRX |
|---|---|---|
| Operating Cash Flow | $89.56M | $37.57M |
| Capital Expenditures | N/A | $-142,000 |
| Free Cash Flow | $31.63M | $-12.46M |
| Debt Repayment | N/A | $-1.25M |
| Common Stock Repurchase | N/A | $-99.90M |
Short Interest & Institutional Ownership Analysis
| Metric | TDOC | GDRX |
|---|---|---|
| Shares Short | 24.01M | 6.37M |
| Short Ratio | 3.17 | 5.30 |
| Short % of Float | 0.15% | 0.07% |
| Average Daily Volume (10 Day) | 5,593,154 | 9,322,760 |
| Average Daily Volume (90 Day) | 7,100,158 | 4,062,733 |
| Shares Outstanding | 173.41M | 382.82M |
| Float Shares | 174.77M | 86.44M |
| % Held by Insiders | 0.01% | 0.13% |
| % Held by Institutions | 0.74% | 0.63% |
Dividend Analysis & Yield Comparison: Teladoc Health vs GoodRx Holdings
| Metric | TDOC | GDRX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |